ASLAN Pharma

ASLNNASDAQ
$1.93
-0.45-18.91%
At Close: -
$2.00
0.073.63%
After Hours: 7:55 PM EDT
15 minutes delayed
ASLAN Pharmaceuticals Ltd is expected to split Wednesday, July 3, 2024 with a ratio of 1:8
Consensus Rating1
Buy
Highest Price Target1
$15.00
Lowest Price Target1
$8.00
Consensus Price Target1
$10.50

want to know what
the Bulls & Bears Say?

ASLAN Pharma (NASDAQ:ASLN) Stock, Analyst Ratings, Price Targets, Forecasts

ASLAN Pharmaceuticals Ltd has a consensus price target of $10.5 based on the ratings of 23 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 3, 2024, April 23, 2024, and April 15, 2024, respectively. With an average price target of $9 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 350.00% upside for ASLAN Pharmaceuticals Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Mar
0
0
0
0
Apr
0
0
0
0
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Piper Sandler
Roth MKM
Jefferies

1calculated from analyst ratings

Analyst Ratings for ASLAN Pharma

Buy NowGet Alert
05/03/2024Buy Now350%HC Wainwright & Co.
Yi Chen
$72 → $72ReiteratesBuy → BuyGet Alert
04/23/2024Buy Now350%HC Wainwright & Co.
Yi Chen
$72 → $72ReiteratesBuy → BuyGet Alert
04/15/2024Buy Now350%HC Wainwright & Co.
Yi Chen
$72 → $72ReiteratesBuy → BuyGet Alert
03/18/2024Buy Now350%HC Wainwright & Co.
Yi Chen
$136 → $72MaintainsBuyGet Alert
03/13/2024Buy Now400%Piper Sandler
Edward Tenthoff
$120 → $80ReiteratesOverweight → OverweightGet Alert
03/11/2024Buy Now650%Piper Sandler
Edward Tenthoff
$120 → $120MaintainsOverweightGet Alert
11/06/2023Buy Now750%HC Wainwright & Co.
Yi Chen
→ $136ReiteratesBuy → BuyGet Alert
08/14/2023Buy Now650%Roth MKM
Dylan Dupuis
→ $120ReiteratesBuy → BuyGet Alert
08/14/2023Buy Now750%HC Wainwright & Co.
Yi Chen
→ $136ReiteratesBuy → BuyGet Alert
07/07/2023Buy Now750%HC Wainwright & Co.
Yi Chen
→ $136ReiteratesBuy → BuyGet Alert
06/26/2023Buy Now750%HC Wainwright & Co.
Yi Chen
→ $136ReiteratesBuy → BuyGet Alert
06/23/2023Buy Now750%HC Wainwright & Co.
Yi Chen
→ $136ReiteratesBuy → BuyGet Alert
05/31/2023Buy Now650%Roth MKM
Dylan Dupuis
→ $120Initiates → BuyGet Alert
04/28/2023Buy Now750%HC Wainwright & Co.
Yi Chen
$160 → $136MaintainsBuyGet Alert
03/27/2023Buy Now900%HC Wainwright & Co.
Yi Chen
→ $160Reiterates → BuyGet Alert
03/20/2023Buy Now900%HC Wainwright & Co.
Yi Chen
→ $160Reiterates → BuyGet Alert
03/01/2023Buy Now125%HC Wainwright & Co.
Yi Chen
→ $180Reiterates → BuyGet Alert
02/27/2023Buy Now50%Piper Sandler
Edward Tenthoff
$160 → $120MaintainsOverweightGet Alert
02/27/2023Buy Now125%HC Wainwright & Co.
Yi Chen
$280 → $180MaintainsBuyGet Alert
09/16/2022Buy Now100%Piper Sandler
Edward Tenthoff
$120 → $160MaintainsOverweightGet Alert
08/15/2022Buy Now250%HC Wainwright & Co.
Yi Chen
$320 → $280MaintainsBuyGet Alert
05/23/2022Buy Now50%Piper Sandler
Edward Tenthoff
$320 → $120MaintainsOverweightGet Alert
07/09/2021Buy Now300%Jefferies
Maury Raycroft
→ $320Initiates → BuyGet Alert

FAQ

Q

What is the target price for ASLAN Pharma (ASLN) stock?

A

The latest price target for ASLAN Pharma (NASDAQ:ASLN) was reported by HC Wainwright & Co. on May 3, 2024. The analyst firm set a price target for $9.00 expecting ASLN to rise to within 12 months (a possible 350.00% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for ASLAN Pharma (ASLN)?

A

The latest analyst rating for ASLAN Pharma (NASDAQ:ASLN) was provided by HC Wainwright & Co., and ASLAN Pharma reiterated their buy rating.

Q

When was the last upgrade for ASLAN Pharma (ASLN)?

A

There is no last upgrade for ASLAN Pharma

Q

When was the last downgrade for ASLAN Pharma (ASLN)?

A

There is no last downgrade for ASLAN Pharma.

Q

When is the next analyst rating going to be posted or updated for ASLAN Pharma (ASLN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ASLAN Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ASLAN Pharma was filed on May 3, 2024 so you should expect the next rating to be made available sometime around May 3, 2025.

Q

Is the Analyst Rating ASLAN Pharma (ASLN) correct?

A

While ratings are subjective and will change, the latest ASLAN Pharma (ASLN) rating was a reiterated with a price target of $9.00 to $9.00. The current price ASLAN Pharma (ASLN) is trading at is $2.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch